CD274 and neoplasm: Importantly, the combined targeting of IL6 with PD‐1/PD‐L1 and blocking of TNF and PD‐1 enables to increase the efficacy of PD‐1/PD‐L1 treatment, which significantly reduce tumor progression.117, 118, 120